Ethics committee
An ethics committee is a body responsible for ensuring that
Specific regions
An ethics committee in the European Union is a body responsible for oversight of medical or human research studies in EU member states. Local terms for a European ethics committee include:
- A Research Ethics Committee (REC) in the United Kingdom[1]
- A Medical Research Ethics Committee (MREC) in the Netherlands.[2]
- A Comité de Protection des Personnes (CPP) in France.
In the United States, an ethics committee is usually known as an
In Australia, an ethics committee in medical research refers to a Human Research Ethics Committee (HREC).
Since 1977 for the purposes of its subsidies to university research the
History
One of the most fundamental ethical principles in human experimentation is that the experimenter should not subject the participants in the experiment to any procedure they would not be willing to undertake themselves. This idea was first codified in the
Another ethical principle is that volunteers must stand to gain some benefit from the research, even if that is only a remote future possibility of treatment being found for a disease that they only have a small chance of contracting. Tests on experimental drugs are sometimes conducted on sufferers of an untreatable condition. If the researcher does not have that condition then there can be no possible benefit to them personally. For instance, Ronald C. Desrosiers in responding to why he did not test an
An important element of an ethics committee's oversight is to ensure that
The convening of ethics committees to approve the research protocol in human experiments was first written into international guidelines in the first revision to the Declaration of Helsinki (Helsinki II, 1975).[15] A controversy arose over the fourth revision (1996) concerning placebo trials in developing countries. It was claimed that US trials of the anti-HIV drug zidovudine in India was in breach of this requirement. This led the US Food and Drug Administration to cease incorporating new revisions of Helsinki and refer instead to the 1989 revision.[16]
Ethics committees are also made a requirement in
See also
References
- PMID 28523118.
- PMID 28523118.
- ^ JSTOR 1174532.
- ^ "Acts of the Parliament of Canada (30th Parliament, 2nd Session, Chapter 1-32), 1976-1977". Queen's Printer. Internet Archive. October 1977.
- ^ a b Fisher, Donald; Rubenson, Kjell; al, et (2006). Canadian Federal Policy and Postsecondary Education (PDF). Vancouver: The Centre for Policy Studies in Higher Education and Training.
- ^ a b c d "TCPS 2 Interpretations - Scope". Government of Canada. Panel on Research Ethics. 2022-06-24.
- ^ "Navigating the Ethics of Human Research". Interagency Advisory Panel on Research Ethics. 2020-02-25.
- ^ "NRC policy for research involving human participants". Government of Canada. National Research Council Canada. 2019-03-26.
- ^ The Nuremberg Code, U.S. Department of Health & Human Services, accessed and archived, 20 December 2015
- ^ Altman, pp. xv-xvii
- ^ Altman, p. xx
- ^ Gandevia, p. 43
- ^ Altman, pp. xvi,157
- ^ Gandevia, pp. 43–44
- ^ Riis, p. 173
- ^
- Carlson, Boyd & Webb, pp. 698-699
- Levine, p. 170
- ^ Largent, p. 207
Bibliography
- Lawrence K. Altman, Who Goes First?: The Story of Self-experimentation in Medicine, University of California Press, 1987 ISBN 0520212819.
- S. C. Gandevia, "Self-experimentation, ethics, and efficacy", Monash Bioethics Review (Ethics Committee Supplement), vol. 23, no. 4, 2005.
- Povl Riis, "Planning of scientific-ethical committees", British Medical Journal, vol. 2, pp. 173–174, 1977.
- Emily A. Largent, "Recently proposed changes to legal and ethical guidelines governing human subjects research", Journal of Law and the Biosciences, vol. 3, iss. 1, pp. 206–216.
- R. J. Levine, "Some recent developments in the international guidelines on the ethics of research involving human subjects", Annals of the New York Academy of Sciences, vol. 918, pp. 170–178, November 2000.
- Robert V Carlson, Kenneth M. Boyd, David J Webb, "The revision of the Declaration of Helsinki: past, present and future", British Journal of Clinical Pharmacology, vol. 57, iss. 6, pp. 695–713, June 2004.